Previous 10 | Next 10 |
Summary Qiagen is seeing a pandemic-driven hangover in its financial results, but underlying double-digit revenue growth was ahead of expectations. The pandemic meaningfully accelerated system placements for its sample prep, diagnostics, and PCR businesses, and now management can shift ...
Danaher Announces New Environmental and Applied Solutions Company to Be Named Veralto PR Newswire WASHINGTON , Feb. 8, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") today announced that Veralto Corporation ("Veralto" or the "Company") will be t...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: shutterstock.com/Champhei Catalent (NYSE: CTLT ), which manufactures pharmaceutical products, is soaring more than 20% in early trading today. Over the weekend, Bloomberg reported that Danaher (NYSE: DHR...
Summary Fisher’s 13F portfolio value increased from ~$133B to ~$148B in Q4 2022. They increased Advanced Micro Devices, Lam Research, and Intuit while decreasing Nvidia, Meta Platforms, PayPal Holdings, and Broadcom. The top three positions are Apple, Microsoft, and Amazon. T...
Life sciences company Danaher Corporation ( NYSE: DHR ) has expressed interest in acquiring the contract manufacturer Catalent ( NYSE: CTLT ), Bloomberg reported Saturday, citing people familiar with the matter. According to the sources, the recent moves by the Washington-...
Summary Dover's revenue growth was a little below average for a multi-industrial, but the margin performance was a little better, and guidance was reassuring. While orders are likely to decelerate further, Dover looks well-placed to generate better results when demand recovers. Mid ...
Summary My January 2023 income is multiples higher than my January 2022 dividend income. I made two sales in my portfolio and added one new position. Six of my portfolio companies increased their dividends and I'm anticipating several February dividend raises. I’m e...
Summary Fortive beat sell-side expectations with strong results from the IOS and PT segments driving 14% organic growth and beats at the revenue and EBITA lines. A macro slowdown is a threat to Tektronix and Fluke, but Fortive has a good mix of less cyclical and acyclical businesses and...
Summary The management team at GE HealthCare Technologies Inc. announced financial results covering the final quarter of the company's 2022 fiscal year. This release cleared up a lot of uncertainty regarding the company and established management's thoughts for the 2023 fiscal year. ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips On the surface, it may seem as if now’s not the time to buy industrial stocks. With macro issues still unresolved, and the threat of a 2023 global recession still looming, there is a lot of uncertainty surrounding the ne...
News, Short Squeeze, Breakout and More Instantly...
2024-07-26 10:45:04 ET Pacific Biosciences of California Inc (PACB) PACB is trading UP for the last 5 days, and it at trading at $2.10 with volume of 3,952,245 and a one day change of $0.19 (9.97%). Pacific Biosciences of California Inc has a 52-week low of 1.16 and a 52-week high o...
Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration PR Newswire BREA, Calif. , July 25, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the Dx...
2024-07-23 20:30:03 ET Goldman Sachs analyst issues NEUTRAL recommendation for DHR on July 23, 2024 06:19PM ET. The previous analyst recommendation was Neutral. DHR was trading at $264.18 at issue of the analyst recommendation. The overall analyst consensus : BUY. Cu...